Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...
Tagrisso combined with chemotherapy improved overall survival in EGFR-mutated NSCLC patients, including those with poor ...
Al Jazeera on MSN
Fact-checking RFK Jr’s false claim linking autism to circumcision
The US health secretary’s claims are false, as research finds no clear connection between circumcision and autism.
KEYTRUDA is indicated for the treatment of patients with resectable (tumors ≥4 cm or node positive) NSCLC in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then ...
Although desmoid tumors do not metastasize, they can be associated with recurrence rates of up to 77% after surgical ...
Objective This study aimed to determine the proportion of capacity challenges for refusal of care, the risk factors that may ...
(Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced results from the Phase 3 ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
TipRanks on MSN
IO Biotech reports expanded Cylembio results
IO Biotech (IOBT) presented detailed results from its global Phase 3 trial of Cylembio, in combination with Merck’s (MRK) anti-PD-1 therapy ...
When the controversial show The Telepathy Tapes hit the airwaves in late 2024, it did what few podcasts manage to do: make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback